The inaugural International Congress for Ataxia Research will be held on 1 – 4 November, Dallas.
Featured topics include: gene discovery, disease mechanisms, cerebellar non-motor circuits and functions, emerging and existing therapeutics, biomarkers and late breaking research. ICAR will also feature workshops with practical demonstrations, discussions on challenges of new and established technologies, and sessions specifically designed by and for junior investigators.
Redenlab’s CEO Dr Adam Vogel is among industry leaders who will be presenting at this year’s conference.
To find out more and register, click here.
